Samuel Abbou
Impact in
-
- Cancer Genomics and Diagnostics
-
- Neuroblastoma Research and Treatments
Papers in
-
- Cancer Genomics and Diagnostics 8
- Oncology 8
- Cancer-related Molecular Pathways 2
- Co-authors
- Brian D. Crompton (4 shared papers)Steven G. DuBois (2 shared papers)David S. Shulman (2 shared papers)Birgit Geoerger (8 shared papers)Gilles Vassal (7 shared papers)Corinne Laplace‐Builhé (1 shared paper)Estelle Daudigeos‐Dubus (2 shared papers)Claudia Lanvers‐Kaminsky (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)Blood (2 papers)Pharmaceutics (1 paper)Neuro-Oncology (1 paper)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Samuel Abbou
28 papers receiving 198 citations
Peers
Comparison fields: 5 of 42
- Cancer Research 50
- Neurology 43
- Genetics 29
- Pathology and Forensic Medicine 43
- Oncology 45
Countries citing papers authored by Samuel Abbou
This map shows the geographic impact of Samuel Abbou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Abbou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Abbou more than expected).
Fields of papers citing papers by Samuel Abbou
This network shows the impact of papers produced by Samuel Abbou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Abbou. The network helps show where Samuel Abbou may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Abbou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 41 | |
| 2 | Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies. | 2016 | 21 |
| 3 | 2023 | 19 | |
| 4 | 2017 | 17 | |
| 5 | 2021 | 12 | |
| 6 | 2017 | 8 | |
| 7 | 2025 | 8 | |
| 8 | 2022 | 7 | |
| 9 | 2015 | 6 | |
| 10 | 2022 | 6 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2024 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Samuel Abbou
Samuel Abbou is a scholar working on Cancer Research, Oncology, Neurology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 31 papers that have together received 199 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Glioma Diagnosis and Treatment (6 papers), Sarcoma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Microtubule and mitosis dynamics (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (50 citations), Neurology (43 citations), Genetics (29 citations), Pathology and Forensic Medicine (43 citations) and Oncology (45 citations). Samuel Abbou has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Brian D. Crompton, Steven G. DuBois, David S. Shulman, Birgit Geoerger, Gilles Vassal, Corinne Laplace‐Builhé, Estelle Daudigeos‐Dubus, Claudia Lanvers‐Kaminsky, Ludivine Le Dret and Jan J. Molenaar. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Blood, Pharmaceutics and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.